STOCK TITAN

EDAP TMS S.A. (EDAP) files Pre-Effective Amendment No.1 with Jones Day opinion

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
S-3/A

Rhea-AI Filing Summary

EDAP TMS S.A. files Pre-Effective Amendment No. 1 to its Registration Statement (File No. 333-294597), submitting an opinion of Jones Day as Exhibit 5.1. The amendment is exhibit-only; the prospectus and the balance of Part II are unchanged.

The filing includes an exhibit index listing corporate charters, deposit agreements, warrants, financing documents with the European Investment Bank, consents, and the calculation of filing fee table. The registration statement is signed by management on March 27, 2026.

Positive

  • None.

Negative

  • None.

Insights

Pre-effective amendment adds legal opinion without changing offering terms.

The filing submits an opinion of Jones Day as Exhibit 5.1 and is styled as a pre-effective amendment to Registration Statement 333-294597. The explanatory note states the amendment is exhibit-only and that the prospectus and remaining Part II are unchanged.

Cash‑flow treatment and any offering quantities are not stated in this excerpt; timing remains tied to the registration statement's effectiveness procedures and signatures dated March 27, 2026. Subsequent filings or the prospectus supplement would show offering terms if they change.

As filed with the Securities and Exchange Commission on March 27, 2026

Registration No. 333-294597

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-3

(Amendment No. 1)

 

REGISTRATION STATEMENT

UNDER
THE SECURITIES ACT OF 1933

_________________________________

 

EDAP TMS S.A.

(Exact name of registrant as specified in its charter)

_________________________________

 

France   Not applicable
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

Parc d’Activités la Poudrette-Lamartine

4/6, rue du Dauphiné

69120 Vaulx-en-Velin, France

+33(0) 4 72 15 31 50

(Address, including zip code, and telephone number, including area code of registrant’s principal executive offices)

 

EDAP Technomed Inc.

5321 Industrial Oaks Blvd, Suite 110

Austin, TX 78735

U.S.A.

Tel: + 1 512 832 7956

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

 

Sanket Shah
EDAP TMS S.A.
4/6, rue du Dauphiné
69120 Vaulx-en-Velin, France
+33(0) 4 72 15 31 50
Jeremy Cleveland
JONES DAY
1755 Embarcadero Road
Palo Alto, California 94303
(650) 739-3939

 

From time to time after the effective date of this Registration Statement

(Approximate date of commencement of proposed sale to the public)

 

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

 

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 

 

 

 

 

Explanatory Note

 

EDAP TMS S.A. is hereby filing this Pre-Effective Amendment No. 1 to the Registration Statement on Form S-3 (Registration No. 333-294597), originally filed on March 25, 2026 (the “Registration Statement”), as an exhibit-only filing to file an opinion of Jones Day, filed herewith as Exhibit 5.1 (the “Opinion”). Accordingly, this Pre-Effective Amendment No. 1 consists only of the facing page, this explanatory note, Item 16 of Part II of the Registration Statement, the signature pages to the Registration Statement, and the Opinion filed herewith as Exhibit 5.1. The prospectus and the balance of Part II of the Registration Statement are unchanged and have been omitted.

 

 

Item 16. Exhibits.

 

A list of exhibits filed with this registration statement is set forth in the Exhibit Index, and such exhibits are incorporated into this Item 16 by reference.

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, EDAP TMS S.A. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Los Altos, United States of America, on March 27, 2026.

 

  EDAP TMS S.A.
   
   
   
  By: /s/ Ryan Rhodes
  Name:  Ryan Rhodes
  Title:  Chief Executive Officer and Director

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities indicated on March 27, 2026.

 

 

Signature

 

Title

 

Date

         

/s/ Ryan Rhodes

Ryan Rhodes

  Chief Executive Officer and Director
(Principal Executive Officer)
  March 27, 2026
         

/s/ *

Ken Mobeck

  Chief Financial Officer
(Principal Financial Officer)
  March 27, 2026
         

/s/ *

François Dietsch

  Chief Accounting Officer
(Principal Accounting Officer)
  March 27, 2026
         

/s/ *

Lance Willsey

  Chairman of the Board and Director   March 27, 2026
         

/s/ *

Fran Schulz

  Director   March 27, 2026
         

/s/ *

Josh Levine

  Director   March 27, 2026
         

/s/ *

David Horn

  Director   March 27, 2026

 

* By: /s/ Ryan Rhodes  
  Ryan Rhodes, Attorney-in-Fact, March 27, 2026

 

 

 

 

 

 

 

AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-3 has been signed by the undersigned as the duly authorized representative in the United States of EDAP TMS S.A. in the City of Los Altos, United States of America, on March 27, 2026.

 

  EDAP TMS S.A.
   
   
   
  By: /s/ Ryan Rhodes
  Name:  Ryan Rhodes
  Title:  Chief Executive Officer and Director

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.

 

Description

1.1*   Form of Underwriting Agreement.
3.1**   By-laws (statuts) of EDAP TMS S.A. (English translation) as amended as of December 18, 2025 (Incorporated herein by reference to Exhibit 3.1 of EDAP TMS S.A.’s Annual Report on Form 10-K for the year ended December 31, 2025 filed March 25, 2026, SEC File Number 000-29374).
4.1**   Form of Amended and Restated Deposit Agreement between EDAP TMS S.A., The Bank of New York Mellon, as depositary and owners and beneficial owners of American Depositary Shares issued thereunder (incorporated herein by reference to Exhibit 1.2 to Form F-6 dated September 15, 2011, SEC File No. 333-176843).
4.2**   Form of American Depositary Receipt (included in Exhibit 4.1).
4.3*   Form of Warrant.
5.1   Opinion of Jones Day, French counsel to the registrant.
5.2**   Opinion of Jones Day, counsel to the registrant (incorporated herein by reference to Exhibit 5.2 to Form S-3 dated March 25, 2026, SEC File No. 333-294597).
10.1**   Finance Contract, dated as of October 17, 2025, between the Company and the European Investment Bank (incorporated herein by reference to Exhibit 99.1 to Form 6-K dated October 20, 2025, SEC File No. 000-29374).
10.2**   Warrant Agreement, dated as of October 17, 2025, between the Company and the European Investment Bank (incorporated herein by reference to Exhibit 99.2 to Form 6-K dated October 20, 2025, SEC File No. 000-29374).
23.1**   Consent of KPMG S.A. (incorporated herein by reference to Exhibit 23.1 to Form S-3 dated March 25, 2026, SEC File No. 333-294597)
23.2   Consent of Jones Day (included in Exhibits 5.1 and 5.2 (incorporated herein by reference to Exhibit 5.2 to Form S-3 dated March 25, 2026, SEC File No. 333-294597)).
24.1**   Powers of Attorney (incorporated herein by reference to the signature pages to Form S-3 dated March 25, 2026, SEC File No. 333-294597).
107**   Calculation of Filing Fee Table (incorporated herein by reference to Exhibit 107 to Form S-3 dated March 25, 2026, SEC File No. 333-294597)

________________

*To be filed, if necessary, subsequent to the effectiveness of this Registration Statement by an amendment to this Registration Statement or as an exhibit to a report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and incorporated herein by reference.

 

**Filed previously 

 

 

 

FAQ

What did EDAP (EDAP) file in this Pre-Effective Amendment No. 1?

The company filed a Pre-Effective Amendment No. 1 to Registration Statement 333-294597, furnishing a legal opinion from Jones Day as Exhibit 5.1. The filing is exhibit-only and leaves the prospectus and Part II unchanged.

Does this amendment change the prospectus or offering terms for EDAP?

No. The explanatory note states the amendment is exhibit-only and that the prospectus and the balance of Part II of the registration statement are unchanged. Offering terms are not modified in this excerpt.

Which exhibits are newly included or referenced in the filing?

The filing includes Exhibit 5.1 (Jones Day opinion) and references an exhibit index listing bylaws, deposit agreements, warrants, finance and warrant agreements with the European Investment Bank, consents, and the filing fee table.

Who signed the registration statement amendment for EDAP and when?

The registration statement was signed on behalf of EDAP TMS S.A. by Ryan Rhodes, Chief Executive Officer and Director, and other officers and directors on March 27, 2026.

Does the amendment disclose offering size, proceeds, or registration amounts?

This excerpt does not state any offering size, proceeds, or registered securities amounts. The amendment is limited to exhibit filings and the exhibit index; offering quantities are not provided here.
Edap Tms

NASDAQ:EDAP

View EDAP Stock Overview

EDAP Rankings

EDAP Latest News

EDAP Latest SEC Filings

EDAP Stock Data

140.97M
35.74M
Medical Distribution
Electromedical & Electrotherapeutic Apparatus
Link
France
69120 VAULX EN VELIN